Topic An international, expert-led consensus initiative to develop systematic, evidence-
based recommendations for the treatment of noninfectious uveitis in the era of biologics …

Birdshot chorioretinopathy (BCR) is a rare form of chronic, bilateral, posterior uveitis with a
distinctive clinical phenotype, and a strong association with HLA-A29. It predominantly …

Macular edema (ME) represents the most common cause for visual loss among uveitis
patients. The management of uveitic macular edema (UME) may be challenging, due to its …

Macular edema (ME) is a major complication of several vascular and inflammatory retinal
diseases. Multiple mechanisms are implicated in its development and lead to visual …

Introduction: Conventional immunosuppressive drugs, anti-TNF alpha treatments and
biotherapies are increasingly being used in non-infectious uveitis. Areas covered: The …

The appraisal of HLA-A29 birdshot retinochoroiditis (BRC) was fraught with pitfalls and
misunderstandings. Progress in investigational methods has led to better knowledge and …

Non-infectious choroiditis comprises immune-mediated diseases resulting from diverse
pathophysiological mechanisms. These conditions are sub-divided into two main groups,(1) …

Birdshot Retinochoroiditis (BSRC) is a progressive non-infectious intraocular inflammation
that affects choroid and retina. Inflammatory processes have adverse effects on vision by …

Building and analyzing knowledge graphs (KGs) to aid drug discovery is a topical area of
research. A salient feature of KGs is their ability to combine many heterogeneous data …

Purpose To report the visual prognosis, electroretinography (ERG) and perimetry outcomes
of systemic corticosteroid-sparing immunomodulatory treatment (IMT) for birdshot …